PALO ALTO — It’s going to be a very busy year for lawyers who take companies public.

For months, the buzz on initial public offerings has been all about the renaissance in the life sciences. But after the biggest flurry of activity in biotechs in a decade—14 IPOs priced between Jan. 29 and Feb. 11—IPO lawyers now see a huge wave of straight-tech IPOs lining up.